|
| BC patients | Control | X2 | p-value | Odds ratio | 95% CI |
| n = 218 | n = 178 | LL-UL | ||||
| rs2736098 |
|
|
|
|
|
|
| Genotypes |
|
|
|
|
|
|
| AA | 25 (11.5%) | 48 (27.3%) | 15.456 | <0.001 | 1 | - |
| AG | 161 (73.8%) | 124 (70.5%) | 0.999 | 0.318 | 1.230 | 0.792 - 1.909 |
| GG | 32 (14.7%) | 4 (2.2 %) | 14.774 | <0.001 | 7.484 | 2.593 - 21.597 |
| Alleles |
|
|
|
|
|
|
| A | (48.4%) | (62.5%) | 7.447 | 0.006 | 1 | - |
| G | (51.5%) | (37.5%) | 1.743 | 1.168 - 2.600 | ||
| rs2735940 |
|
|
|
|
|
|
| Genotypes |
|
|
|
|
|
|
| CC | 28 (12.8%) | 30 (16.9%) | 1.255 | 0.263 | 1 | - |
| TC | 95 (43.6%) | 88 (49.4%) | 1.447 | 0.229 | 0.790 | 0.531 - 1.175 |
| TT | 95 (43.6%) | 60 (33.7%) | 4.223 | 0.040 | 1.519 | 1.008-2.289 |
| Alleles |
|
|
|
|
|
|
| C | (36%) | (40%) | 2.567 | 0.109 | 1 | - |
| T | (65%) | (60%) | 1.41 | 0.926 - 2.147 | ||
|
|
|
|
|
|
|
|
| MNS16A |
|
|
|
|
|
|
| Genotypes |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| LL | 80 (36.7%) | 55 (30.9%) | 1.353 | 0.245 | 1 | - |
| LS | 86 (39.4%) | 68 (38.2%) | 0.095 | 0.758 | 1.054 | 0.702 - 1.582 |
| SS | 52 (23.9%) | 55 (30.9%) | 2.458 | 0.117 | 0.701 | 0.449 - 1.093 |
| Alleles |
|
|
|
|
|
|
| L | 56% | 50% | 0.091 | 0.763 | 1 | - |
| S | 44% | 50% | 0.941 | 0.634 - 1.397 |